CS257793B2 - Method of quinoline's derivatives production - Google Patents

Method of quinoline's derivatives production Download PDF

Info

Publication number
CS257793B2
CS257793B2 CS864112A CS411286A CS257793B2 CS 257793 B2 CS257793 B2 CS 257793B2 CS 864112 A CS864112 A CS 864112A CS 411286 A CS411286 A CS 411286A CS 257793 B2 CS257793 B2 CS 257793B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
iii
group
reaction
Prior art date
Application number
CS864112A
Other languages
Czech (cs)
English (en)
Inventor
Edit Berenyi
Laszlo Varga
Laszlo Pallos
Lujza Petoecz
Laszlo Ladanyi
Peter Toempe
Eva Hartai
Agnes Kovacs
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CS257793B2 publication Critical patent/CS257793B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
CS864112A 1985-06-04 1986-06-04 Method of quinoline's derivatives production CS257793B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU852193A HU195487B (en) 1985-06-04 1985-06-04 Process for producing quinoline derivatives

Publications (1)

Publication Number Publication Date
CS257793B2 true CS257793B2 (en) 1988-06-15

Family

ID=10958222

Family Applications (1)

Application Number Title Priority Date Filing Date
CS864112A CS257793B2 (en) 1985-06-04 1986-06-04 Method of quinoline's derivatives production

Country Status (28)

Country Link
US (1) US4652562A (sv)
JP (1) JPS6248668A (sv)
KR (1) KR930006775B1 (sv)
CN (1) CN1012957B (sv)
AT (1) AT392469B (sv)
AU (1) AU588883B2 (sv)
BE (1) BE904864A (sv)
CA (1) CA1266650A (sv)
CH (1) CH668069A5 (sv)
CS (1) CS257793B2 (sv)
DD (1) DD247448A5 (sv)
DE (1) DE3618724C2 (sv)
DK (1) DK162841C (sv)
ES (1) ES8707231A1 (sv)
FI (1) FI82451C (sv)
FR (1) FR2582835B1 (sv)
GB (1) GB2176185B (sv)
GR (1) GR861452B (sv)
HU (1) HU195487B (sv)
IL (1) IL79024A0 (sv)
IT (1) IT1204377B (sv)
NL (1) NL8601434A (sv)
NO (1) NO165635C (sv)
PH (1) PH24135A (sv)
PL (1) PL146498B1 (sv)
PT (1) PT82712B (sv)
SE (1) SE466308B (sv)
SU (1) SU1398773A3 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) * 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US8557298B2 (en) * 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US20090117199A1 (en) * 1998-08-06 2009-05-07 Scott Timothy C Method of treatment of cancer
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
US20020001567A1 (en) * 1998-12-21 2002-01-03 Photogen, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US8470296B2 (en) * 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
EP1719770A3 (en) * 2000-09-21 2008-03-05 Smithkline Beecham Plc Quinoline derivatives as antibacterials

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165520B (sv) * 1972-05-05 1974-09-28
IE47458B1 (en) * 1977-11-07 1984-03-21 Leo Pharm Prod Ltd Quinolylguanidine derivatives

Also Published As

Publication number Publication date
SE8602524D0 (sv) 1986-06-04
DE3618724A1 (de) 1987-01-08
DK162841C (da) 1992-05-04
KR930006775B1 (ko) 1993-07-23
DK262186A (da) 1986-12-05
AT392469B (de) 1991-04-10
ATA149286A (de) 1990-09-15
HUT41008A (en) 1987-03-30
DK162841B (da) 1991-12-16
DK262186D0 (da) 1986-06-04
SE8602524L (sv) 1986-12-05
NO165635B (no) 1990-12-03
IL79024A0 (en) 1986-09-30
HU195487B (en) 1988-05-30
CN1012957B (zh) 1991-06-26
NO862230D0 (no) 1986-06-04
CN86103688A (zh) 1987-02-11
AU588883B2 (en) 1989-09-28
IT8620667A0 (it) 1986-06-04
AU5834486A (en) 1986-12-11
PT82712B (pt) 1988-04-21
JPH0515705B2 (sv) 1993-03-02
US4652562A (en) 1987-03-24
NL8601434A (nl) 1987-01-02
PH24135A (en) 1990-03-05
GB2176185A (en) 1986-12-17
GB8613530D0 (en) 1986-07-09
FI82451B (fi) 1990-11-30
FR2582835A1 (fr) 1986-12-05
BE904864A (fr) 1986-12-03
SE466308B (sv) 1992-01-27
SU1398773A3 (ru) 1988-05-23
DD247448A5 (de) 1987-07-08
JPS6248668A (ja) 1987-03-03
NO862230L (no) 1986-12-05
IT1204377B (it) 1989-03-01
GB2176185B (en) 1988-09-28
DE3618724C2 (de) 1994-06-16
FI82451C (sv) 1991-03-11
FI862381A (fi) 1986-12-05
ES555708A0 (es) 1987-07-16
CA1266650A (en) 1990-03-13
KR870000324A (ko) 1987-02-17
FR2582835B1 (fr) 1989-01-06
ES8707231A1 (es) 1987-07-16
FI862381A0 (fi) 1986-06-04
CH668069A5 (de) 1988-11-30
PL146498B1 (en) 1989-02-28
GR861452B (en) 1986-10-03
PT82712A (en) 1986-07-01
NO165635C (no) 1991-03-13

Similar Documents

Publication Publication Date Title
Apelt et al. Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity
Howard et al. Hydrophobicity of several rhodium (II) carboxylates correlated with their biologic activity
KR102216701B1 (ko) 바이구아나이드 화합물 및 이의 용도
US4282232A (en) Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
US20090018145A1 (en) Compositions and their use as anti-tumor agents
NL8402769A (nl) 1-heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl piperazinederivaten; werkwijze voor het bereiden daarvan; farmaceutische preparaten.
CS257793B2 (en) Method of quinoline's derivatives production
JPH0649697B2 (ja) 放射線治療または化学療法に有用な化合物
US5294715A (en) Acridine-intercalator based hypoxia selective cytotoxins
EP1892245B1 (en) Antineoplastic compounds and pharmaceutical compositions thereof
Karaaslan Synthesis and structure elucidation of new benzimidazole amidoxime derivatives
HU207511B (en) Process for producing pirimidinium derivatives, nonionic formes of them and pharmaceutical compositions containing them
US4581349A (en) Certain benzodiimidazoles and their use as radiation sensitizers
EA020976B1 (ru) Фторированные производные 3-гидроксипиридин-4-онов и способы их использования
JP2000212087A (ja) ニトロ―５―デアザフラビン誘導体を有効成分とする放射線増感剤。
EP0316967B1 (en) Fluorine-containing nitroimidazole derivatives and radiosensitizer comprising the same
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
EP0125695B1 (en) 2-bromo-1-tetralone derivatives
RU2267483C2 (ru) 1-(пиридинил-2)-2-азолил-1-(фторфенил)этанолы и их применение в качестве фунгицидов
Alnabti Synthesis of some New Fluorine Substituted 6-Azauracil Derivatives as Biocidal Agents
JPH07149737A (ja) ニトロトリアゾール化合物
Chorn The synthesis and biological testing of new hypoxic cell radiosensitizers
JPS63310873A (ja) ４，５−ジニトロイミダゾ−ル誘導体
CN101157706A (zh) 含卤素芳香亚胺代六钼酸四丁基铵衍生物及其制备和应用
CS258133B2 (cs) Způsob výroby l-heteroaryl-4-[(2,5-pyrrolidindion-l-yl)alkyl]- piperazinových derivátů